Omega Diagnostics Group appoints Jag Grewal as new CEO

– UK, Alva –  Omega Diagnostics Group PLC (LON: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, today announced the appointment of Board member and current Managing Director of the Health and Nutrition Divisio Jag Grewal as CEO with immediate effect, replacing Colin King who will step down from his position with immediate effect.

“I would also like to welcome Jag into this new role and we look forward to working together on the next phase of Omega’s exciting future.” said Board Chairman, Simon Douglas. 

The company also announced that Non-Executive Director Bill Rhodes will also step down from his role at the end of February 2022.

About Jag Grewal

Jag Grewal has been a member of the Omega Board since joining in June 2011 and is currently Managing Director of the Health and Nutrition Division. He has over 25 years’ commercial experience and an extensive network in the fields of in-vitro diagnostics, life science research and drug discovery.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.